Sagimet Biosciences (SGMT) stock dips as Chinese partner Ascletis (ASCLF) reports Phase 3 trial data for the U.S. firm's acne ...
Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label ...
Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label study - The ...
WEIFANG, SHANDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- 1. Rising Global Demand for PDT LED Light Therapy As ...
New Zealand's Kanuka oil is emerging as a potent skincare contender, challenging Manuka oil's reign.
From contrast therapy to rhythmic health, experts are placing renewed focus on recovery, rest, and repair. Read on for some ...
From contrast therapy to rhythmic health, experts are predicting a renewed focus on recovery, rest, and repair The wellness ...
You'll feel like you deserve a Nobel Prize when your packages arrive. View Entire Post › ...
Initiating testosterone in transmasculine patients and estradiol in transfeminine patients increases acne risk, according to ...
It's like having a microneedling treatment at home, without the needles.
Discover the top 3 undervalued Personal Care Products stocks for Thursday, January 29 based on AAII’s Stock Grades.
A cohort study finds the risk for acne in patients on JAK inhibitors for atopic dermatitis was about 2.5 times greater than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results